Durgical
EN
Open the app

Acromegaly: IGF-1, the glucose load and the face that changed

  • Diagnostic test

Acromegaly changes a face so slowly that family and doctors miss it for years. A blood test called IGF-1 catches it, and a sugar drink confirms it.

Updated

See it in 3D: Pituitary gland · Sella turcica

What it is

Acromegaly is the result of growth hormone (GH) excess after the growth plates have closed; before closure it causes gigantism. Almost all cases come from a GH-secreting pituitary adenoma, most of them macroadenomas by the time of diagnosis; ectopic GHRH secretion is rare. GH acts largely through insulin-like growth factor 1 (IGF-1), made in the liver. The workup screens with IGF-1, confirms with an oral glucose tolerance test that fails to suppress GH, images the pituitary, and looks for the complications that shorten life: diabetes, hypertension, cardiomyopathy, sleep apnoea and colon polyps.

How to read the result

  • IGF-1 above the age- and sex-adjusted range is the screening test; it reflects GH over the previous weeks.
  • Confirmation: GH that does not fall below the assay cut-off (commonly 1 µg/L, or 0.4 µg/L with sensitive assays) during an oral glucose tolerance test.
  • IGF-1 is falsely low in liver disease, malnutrition, poorly controlled diabetes, hypothyroidism and with oral oestrogen; it is normally high in puberty and pregnancy.
  • A random GH is not diagnostic: healthy pulses and stress can make it high.
  • Clues: larger hands and feet (rings and shoes no longer fit), coarse face, jaw growth with gaps between teeth, sweating, carpal tunnel syndrome, headaches and joint pain.
  • Diagnosis is typically delayed by several years; comparing old photographs is a useful bedside test.
  • Acromegaly can be part of an inherited syndrome (MEN1, Carney complex, AIP mutation), especially in young patients.

How it is done

  1. Suspect it from the features, or from an incidental pituitary mass.
  2. Measure IGF-1 and read it against the range for age and sex.
  3. IGF-1 high or equivocal: oral glucose tolerance test with timed GH samples.
  4. GH not suppressed: pituitary MRI with contrast.
  5. Test the rest of the pituitary (prolactin, cortisol, thyroid, gonadal axis) and visual fields if the tumour reaches the chiasm.
  6. Screen complications: glucose and HbA1c, blood pressure, echocardiogram, sleep study, colonoscopy and thyroid examination.

Reading IGF-1 and the glucose-suppressed GH together

IGF-1GH after glucoseMeaning
HighNot suppressedAcromegaly: image the pituitary
NormalSuppressedAcromegaly excluded
HighSuppressedPuberty, pregnancy, assay problem; repeat or reconsider
Normal or lowNot suppressedUncontrolled diabetes, liver or kidney failure, malnutrition, anorexia, oral oestrogen

Common pitfalls

  • The glucose test is hard to read in uncontrolled diabetes, kidney or liver failure and anorexia: GH can fail to suppress without acromegaly.
  • During treatment with a GH receptor antagonist, GH rises and the GH assay is unreliable: monitor IGF-1 only.
  • «Pseudoacromegaly» (coarse features from insulin resistance or drugs) has a normal IGF-1.

Next step / Initial management

  • IGF-1 first; glucose-suppressed GH to confirm; pituitary MRI only after biochemical confirmation.
  • Transsphenoidal surgery is the first-line treatment for most patients; cure is judged on IGF-1 and GH about three months after surgery.
  • Not cured or not operable: somatostatin analogues, a GH receptor antagonist, sometimes cabergoline, and radiotherapy.
  • Refer every suspected case to endocrinology and an experienced pituitary surgeon.

Common traps

  • A random GH confirms or excludes acromegaly: GH is pulsatile, so a single random value can do neither.
  • IGF-1 can be read against the adult range in anyone: in a teenager or pregnant woman the adult range does not apply.
  • An adenoma on MRI confirms acromegaly: going straight to MRI without biochemical confirmation finds non-functioning incidental adenomas.
  • GH tracks control on a GH receptor antagonist: it does not, so GH is not monitored in a patient on this drug.
  • Treating the tumour is the whole job: the heart, sleep apnoea and colon screening decide survival and must not be forgotten.

Test yourself

Think of the answer, then tap the question to see it.

Why is IGF-1, rather than a random GH, the screening test for acromegaly?

GH is secreted in pulses and varies minute to minute; IGF-1 integrates GH action over weeks and is stable.

What is the principle behind the oral glucose tolerance test in acromegaly?

Suspected excess is tested by suppression: glucose normally switches GH off, but an autonomous adenoma keeps secreting.

A man with poorly controlled diabetes has a normal IGF-1 but GH fails to suppress after glucose. Does he have acromegaly?

Probably not: uncontrolled diabetes can blunt GH suppression. A normal IGF-1 argues against acromegaly.

Which value should be used to monitor a patient treated with a GH receptor antagonist, and why?

IGF-1. The drug blocks GH action, so GH itself rises and is measured unreliably.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of endocrinology

Educational content; it does not replace a medical assessment and is not a clinical instruction. For confusion, persistent vomiting with diabetes, fainting or very low blood pressure in someone who takes or has stopped glucocorticoids, go to an emergency department at once.

Sources: Acromegaly (StatPearls (NCBI Bookshelf), 2023); Pituitary Adenoma (StatPearls (NCBI Bookshelf), 2025); Imaging of the Pituitary Gland (StatPearls (NCBI Bookshelf), 2023).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.